These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2829380)

  • 21. The receptor for urokinase-type plasminogen activator of a human keratinocyte line (HaCaT).
    Reinartz J; Link J; Todd RF; Kramer MD
    Exp Cell Res; 1994 Oct; 214(2):486-98. PubMed ID: 7925643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Receptors for plasminogen activator, urokinase, in normal and Rous sarcoma virus-transformed mouse fibroblasts.
    Del Rosso M; Dini G; Fibbi G
    Cancer Res; 1985 Feb; 45(2):630-6. PubMed ID: 2981611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surface-associated plasminogen activation in leukemic cells: interaction with extracellular matrix.
    Martínez J; Santibañez JF
    Eur J Cell Biol; 1994 Aug; 64(2):257-63. PubMed ID: 7813513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ethanol-induced up-regulation of candidate plasminogen receptor annexin II in cultured human endothelial cells.
    Tabengwa EM; Abou-Agag LH; Benza RL; Torres JA; Aikens ML; Booyse FM
    Alcohol Clin Exp Res; 2000 Jun; 24(6):754-61. PubMed ID: 10888061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urokinase-type plasminogen-activator receptor associates to a cell surface molecule in monocytic cells.
    Ragno P; Montuori N; Rossi G
    Biochem Biophys Res Commun; 1996 Jul; 224(1):252-7. PubMed ID: 8694822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.
    Leonardi A; Brun P; Sartori MT; Cortivo R; Dedominicis C; Saggiorato G; Abatangelo G; Secchi AG
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of cell viability dramatically elevates cell surface plasminogen binding and activation.
    O'Mullane MJ; Baker MS
    Exp Cell Res; 1998 Jul; 242(1):153-64. PubMed ID: 9665813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gangliosides interact directly with plasminogen and urokinase and may mediate binding of these fibrinolytic components to cells.
    Miles LA; Dahlberg CM; Levin EG; Plow EF
    Biochemistry; 1989 Nov; 28(24):9337-43. PubMed ID: 2611234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Murine monoclonal antibodies against murine uPA receptor produced in gene-deficient mice: inhibitory effects on receptor-mediated uPA activity in vitro and in vivo.
    Pass J; Jögi A; Lund IK; Rønø B; Rasch MG; Gårdsvoll H; Lund LR; Ploug M; Rømer J; Danø K; Høyer-Hansen G
    Thromb Haemost; 2007 Jun; 97(6):1013-22. PubMed ID: 17549305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The surface of prostate carcinoma DU145 cells mediates the inhibition of urokinase-type plasminogen activator by maspin.
    McGowen R; Biliran H; Sager R; Sheng S
    Cancer Res; 2000 Sep; 60(17):4771-8. PubMed ID: 10987285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasminogen binding properties of macrophage inflammatory protein (MIP)-2alpha.
    Arza B; Félez J; Fábregas P; Laroche Y; Collen D; Lijnen HR
    Thromb Haemost; 2000 Jul; 84(1):71-7. PubMed ID: 10928473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Binding of tissue plasminogen activator to human monocytes and monocytoid cells.
    Felez J; Chanquia CJ; Levin EG; Miles LA; Plow EF
    Blood; 1991 Nov; 78(9):2318-27. PubMed ID: 1932747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of plasminogen receptor expression on human monocytes and monocytoid cell lines.
    Felez J; Miles LA; Plescia J; Plow EF
    J Cell Biol; 1990 Oct; 111(4):1673-83. PubMed ID: 2170426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of the binding of human tissue-type plasminogen activator to platelets.
    Vaughan DE; Mendelsohn ME; Declerck PJ; Van Houtte E; Collen D; Loscalzo J
    J Biol Chem; 1989 Sep; 264(27):15869-74. PubMed ID: 2550424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased plasminogen binding is associated with metastatic breast cancer cells: differential expression of plasminogen binding proteins.
    Ranson M; Andronicos NM; O'Mullane MJ; Baker MS
    Br J Cancer; 1998 May; 77(10):1586-97. PubMed ID: 9635833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A potential basis for the thrombotic risks associated with lipoprotein(a).
    Miles LA; Fless GM; Levin EG; Scanu AM; Plow EF
    Nature; 1989 May; 339(6222):301-3. PubMed ID: 2542796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasminogen receptors, urokinase receptors, and their modulation on human endothelial cells.
    Miles LA; Levin EG; Plescia J; Collen D; Plow EF
    Blood; 1988 Aug; 72(2):628-35. PubMed ID: 2840987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Regulation of fibrinolysis by lymphocytes in inflammatory diseases of the bronchopulmonary system].
    Bratchik AM; Beloglazov VA; Kilessa VV; Kushchenkov IK
    Klin Med (Mosk); 1989 Nov; 67(11):28-31. PubMed ID: 2560507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular receptor for urokinase-type plasminogen activator: function in cell-surface proteolysis.
    Ellis V; Behrendt N; Danø K
    Methods Enzymol; 1993; 223():223-33. PubMed ID: 8271955
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparative study of fibrinolytic activity on 937 line after stimulation by interferon gamma, 1,25 dihydroxyvitamin D3 and their combination.
    Lu H; Li H; Mirshahi SS; Soria C; Soria J; Menashi S
    Thromb Res; 1993 Feb; 69(4):353-9. PubMed ID: 8385811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.